Taiwan
· Delayed Price · Currency is TWD Gwo Xi Stem Cell Applied Technology Co. , Statistics
Total Valuation
Gwo Xi Stem Cell Applied Technology Co. , has a market cap or net worth of TWD 3.09 billion. The enterprise value is 3.15 billion.
| Market Cap | 3.09B |
| Enterprise Value | 3.15B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Gwo Xi Stem Cell Applied Technology Co. , has 95.95 million shares outstanding. The number of shares has increased by 6.48% in one year.
| Shares Outstanding | 95.95M |
| Shares Change (YoY) | +6.48% |
| Shares Change (QoQ) | +5.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.02% |
| Float | 95.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.06 |
| PB Ratio | 4.45 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -30.40 |
| EV / Sales | 20.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 55.55.
| Current Ratio | 3.52 |
| Quick Ratio | 3.38 |
| Debt / Equity | 55.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.31 |
Financial Efficiency
Return on equity (ROE) is -17.66% and return on invested capital (ROIC) is -5.95%.
| Return on Equity (ROE) | -17.66% |
| Return on Assets (ROA) | -5.64% |
| Return on Capital (ROIC) | -5.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.14 |
| Inventory Turnover | 3.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.34% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.34% |
| 50-Day Moving Average | 34.08 |
| 200-Day Moving Average | 34.33 |
| Relative Strength Index (RSI) | 43.46 |
| Average Volume (20 Days) | 106,559 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gwo Xi Stem Cell Applied Technology Co. , had revenue of TWD 150.50 million and -103.67 million in losses. Loss per share was -1.11.
| Revenue | 150.50M |
| Gross Profit | 106.32M |
| Operating Income | -96.41M |
| Pretax Income | -103.66M |
| Net Income | -103.67M |
| EBITDA | -44.35M |
| EBIT | -96.41M |
| Loss Per Share | -1.11 |
Balance Sheet
The company has 329.72 million in cash and 386.70 million in debt, giving a net cash position of -56.98 million or -0.59 per share.
| Cash & Cash Equivalents | 329.72M |
| Total Debt | 386.70M |
| Net Cash | -56.98M |
| Net Cash Per Share | -0.59 |
| Equity (Book Value) | 696.10M |
| Book Value Per Share | 7.25 |
| Working Capital | 260.37M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.65%, with operating and profit margins of -64.06% and -68.89%.
| Gross Margin | 70.65% |
| Operating Margin | -64.06% |
| Pretax Margin | -68.88% |
| Profit Margin | -68.89% |
| EBITDA Margin | -29.47% |
| EBIT Margin | -64.06% |
| FCF Margin | n/a |
Dividends & Yields
Gwo Xi Stem Cell Applied Technology Co. , does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.48% |
| Shareholder Yield | -6.48% |
| Earnings Yield | -3.43% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |